Entera Bio Ltd. Warrant
ENTXW
ENTXW was delisted on the 27th of June, 2023.
1 hedge funds and large institutions have $2K invested in Entera Bio Ltd. Warrant in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
33% less capital invested
Capital invested by funds: $3K → $2K (-$1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$630 |
Top Sellers
ENTXW Hedge Fund Activity: Q4 2018 in Review
1 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Entera Bio Ltd. Warrant (ENTXW) for Q4 2018, worth a combined $2K — down 33% from $3K a quarter earlier.
Fund positioning in ENTXW was balanced in Q4 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $630.
- 1 institutional investor held Entera Bio Ltd. Warrant (ENTXW) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $2K of Entera Bio Ltd. Warrant stock for Q4 2018, down 33% quarter-over-quarter.
- 0 funds opened new Entera Bio Ltd. Warrant positions in Q4 2018 and 0 closed out.
- The largest Entera Bio Ltd. Warrant buyer in Q4 2018 was UBS Group, an estimated $630 added.
Based on aggregated 13F filings for Q4 2018.